Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ)
CNY 7.0
(-2.51%)
CNY 7.0
(-2.51%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 255.9 Million CNY | -9.62% |
| 2022 | 283.15 Million CNY | 8.32% |
| 2021 | 261.4 Million CNY | -69.28% |
| 2020 | 850.88 Million CNY | 23.46% |
| 2019 | 689.18 Million CNY | 31.91% |
| 2018 | 522.46 Million CNY | 21.88% |
| 2017 | 428.66 Million CNY | 136.06% |
| 2016 | 181.58 Million CNY | -41.94% |
| 2015 | 312.77 Million CNY | -12.1% |
| 2014 | 355.84 Million CNY | 23.16% |
| 2013 | 288.92 Million CNY | -11.51% |
| 2012 | 326.52 Million CNY | 0.58% |
| 2011 | 324.64 Million CNY | -3.83% |
| 2010 | 337.57 Million CNY | 36.55% |
| 2009 | 247.22 Million CNY | 38.87% |
| 2008 | 178.01 Million CNY | -15.23% |
| 2007 | 209.99 Million CNY | 38.4% |
| 2006 | 151.72 Million CNY | 36.9% |
| 2005 | 110.82 Million CNY | 66.49% |
| 2004 | 66.56 Million CNY | 33.66% |
| 2003 | 49.8 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 237.16 Million CNY | -7.32% |
| 2024 Q2 | 268.47 Million CNY | 13.2% |
| 2024 Q3 | 297.74 Million CNY | 10.9% |
| 2023 Q2 | 324.99 Million CNY | 16.85% |
| 2023 Q4 | 255.9 Million CNY | -16.9% |
| 2023 Q3 | 307.94 Million CNY | -5.25% |
| 2023 FY | 255.9 Million CNY | -9.62% |
| 2023 Q1 | 278.12 Million CNY | -1.78% |
| 2022 Q1 | 273.42 Million CNY | 4.6% |
| 2022 FY | 283.15 Million CNY | 8.32% |
| 2022 Q4 | 283.15 Million CNY | 0.29% |
| 2022 Q3 | 282.33 Million CNY | 2.36% |
| 2022 Q2 | 275.81 Million CNY | 0.87% |
| 2021 Q1 | 223.52 Million CNY | -73.73% |
| 2021 FY | 261.4 Million CNY | -69.28% |
| 2021 Q3 | 304.27 Million CNY | 8.61% |
| 2021 Q2 | 280.14 Million CNY | 25.33% |
| 2021 Q4 | 261.4 Million CNY | -14.09% |
| 2020 FY | 850.88 Million CNY | 23.46% |
| 2020 Q2 | 782.25 Million CNY | 8.74% |
| 2020 Q3 | 828.76 Million CNY | 5.95% |
| 2020 Q4 | 850.88 Million CNY | 2.67% |
| 2020 Q1 | 719.36 Million CNY | 4.38% |
| 2019 Q3 | 611.28 Million CNY | 8.82% |
| 2019 Q4 | 689.18 Million CNY | 12.74% |
| 2019 FY | 689.18 Million CNY | 31.91% |
| 2019 Q1 | 470.06 Million CNY | -10.03% |
| 2019 Q2 | 561.75 Million CNY | 19.51% |
| 2018 Q2 | 456.97 Million CNY | 26.36% |
| 2018 FY | 522.46 Million CNY | 21.88% |
| 2018 Q4 | 522.46 Million CNY | -1.01% |
| 2018 Q3 | 527.8 Million CNY | 15.5% |
| 2018 Q1 | 361.63 Million CNY | -15.64% |
| 2017 Q1 | 239.32 Million CNY | 31.8% |
| 2017 Q2 | 306.5 Million CNY | 28.07% |
| 2017 FY | 428.66 Million CNY | 136.06% |
| 2017 Q3 | 367.92 Million CNY | 20.04% |
| 2017 Q4 | 428.66 Million CNY | 16.51% |
| 2016 Q3 | 239.42 Million CNY | -24.04% |
| 2016 FY | 181.58 Million CNY | -41.94% |
| 2016 Q4 | 181.58 Million CNY | -24.16% |
| 2016 Q2 | 315.2 Million CNY | -2.4% |
| 2016 Q1 | 322.94 Million CNY | 3.25% |
| 2015 Q2 | 343.53 Million CNY | 24.34% |
| 2015 Q1 | 276.27 Million CNY | -22.36% |
| 2015 FY | 312.77 Million CNY | -12.1% |
| 2015 Q4 | 312.77 Million CNY | -9.96% |
| 2015 Q3 | 347.36 Million CNY | 1.12% |
| 2014 Q1 | 274.4 Million CNY | -5.03% |
| 2014 FY | 355.84 Million CNY | 23.16% |
| 2014 Q2 | 351.3 Million CNY | 28.03% |
| 2014 Q4 | 355.84 Million CNY | 10.45% |
| 2014 Q3 | 322.16 Million CNY | -8.3% |
| 2013 Q3 | 259.63 Million CNY | -3.46% |
| 2013 Q2 | 268.93 Million CNY | -11.92% |
| 2013 Q1 | 305.33 Million CNY | -6.49% |
| 2013 FY | 288.92 Million CNY | -11.51% |
| 2013 Q4 | 288.92 Million CNY | 11.28% |
| 2012 Q4 | 326.52 Million CNY | 8.81% |
| 2012 Q2 | 335.37 Million CNY | 12.93% |
| 2012 Q3 | 300.09 Million CNY | -10.52% |
| 2012 Q1 | 296.97 Million CNY | -8.52% |
| 2012 FY | 326.52 Million CNY | 0.58% |
| 2011 Q3 | 319.98 Million CNY | 0.98% |
| 2011 Q4 | 324.64 Million CNY | 1.46% |
| 2011 FY | 324.64 Million CNY | -3.83% |
| 2011 Q2 | 316.87 Million CNY | 20.92% |
| 2011 Q1 | 262.04 Million CNY | -22.37% |
| 2010 Q2 | 254.31 Million CNY | 28.35% |
| 2010 FY | 337.57 Million CNY | 36.55% |
| 2010 Q1 | 198.13 Million CNY | -19.85% |
| 2010 Q4 | 337.57 Million CNY | 46.44% |
| 2010 Q3 | 230.51 Million CNY | -9.36% |
| 2009 Q1 | 144.66 Million CNY | -18.74% |
| 2009 Q3 | 202.48 Million CNY | 14.28% |
| 2009 Q2 | 177.17 Million CNY | 22.47% |
| 2009 FY | 247.22 Million CNY | 38.87% |
| 2009 Q4 | 247.22 Million CNY | 22.1% |
| 2008 Q2 | 214.87 Million CNY | 15.41% |
| 2008 Q4 | 178.01 Million CNY | -13.28% |
| 2008 Q3 | 205.28 Million CNY | -4.46% |
| 2008 FY | 178.01 Million CNY | -15.23% |
| 2008 Q1 | 186.18 Million CNY | -11.34% |
| 2007 Q4 | 209.99 Million CNY | 11.59% |
| 2007 Q2 | 172.59 Million CNY | 15.86% |
| 2007 Q1 | 148.96 Million CNY | -1.82% |
| 2007 Q3 | 188.18 Million CNY | 9.03% |
| 2007 FY | 209.99 Million CNY | 38.4% |
| 2006 Q2 | 124.41 Million CNY | 0.0% |
| 2006 Q3 | 140.26 Million CNY | 12.74% |
| 2006 Q4 | 151.72 Million CNY | 8.17% |
| 2006 FY | 151.72 Million CNY | 36.9% |
| 2005 FY | 110.82 Million CNY | 66.49% |
| 2005 Q4 | 110.82 Million CNY | 0.0% |
| 2004 FY | 66.56 Million CNY | 33.66% |
| 2003 FY | 49.8 Million CNY | 0.0% |